Key Financial Figures - Standalone (₹ in crore)
Quarter Ended June 30, 2026 (Q1 FY27):
- Revenue from Operations: ₹15,106.27
- Other Income: ₹400.08
- Total Income: ₹15,506.35
- Total Expenses: ₹14,327.48
- Profit Before Tax: ₹1,178.87
- Total Tax Expense: ₹520.84
- Current Tax: ₹15.25
- Deferred Tax: ₹(0.34)
- Short/(Excess) Provision for tax of earlier years: ₹(10.00)
- Net Profit for the period: ₹658.03
- Earnings Per Share (Basic & Diluted): ₹15.99 (annualized)
- Paid-up Equity Share Capital: ₹558.56 crore (Face Value ₹10 each)
- Other Equity: ₹76,187.53
Comparative Figures - Quarter Ended June 30, 2025:
- Revenue from Operations: ₹14,821.54
- Other Income: ₹427.31
- Total Income: ₹15,248.85
- Total Expenses: ₹14,365.45
- Profit Before Tax: ₹883.40
- Total Tax Expense: ₹225.37
- Net Profit for the period: ₹658.08
- Earnings Per Share (Basic & Diluted): ₹15.98 (annualized)
Key Financial Figures - Consolidated (₹ in crore)
Quarter Ended June 30, 2026 (Q1 FY27):
- Revenue from Operations: ₹15,106.27
- Other Income: ₹400.08
- Total Income: ₹15,506.35
- Total Expenses: ₹14,327.52
- Profit Before Tax: ₹1,178.83
- Total Tax Expense: ₹520.84
- Net Profit for the period: ₹658.08
- Earnings Per Share (Basic & Diluted): ₹15.98 (annualized)
Dates and Approvals
- Board Meeting Date: August 7, 2026 (2:00 PM to 3:30 PM)
- Audit Committee Meeting: August 7, 2026 (prior to Board meeting)
- Trading Window Closure: July 1, 2026 to August 9, 2026
- Trading Window Re-opening: August 10, 2026
Subsidiary Information
Consolidated results include Transpek Creative Chemistry Private Limited, a wholly-owned subsidiary.
Business Segment
The Company is engaged in the business of manufacturing "Chemicals," which is the only operating segment as per Ind AS 108.
Basis of Preparation
The financial results have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standards (Ind AS) 34, "Interim Financial Reporting" prescribed under Section 133 of the Companies Act, 2013.